These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5897741)

  • 1. Absorption and excretion of radioactively tagged dextroamphetamine sulfate from a sustained-release preparation.
    Rosen E; Tannenbaum P; Ellison T; Free SM; Crosley AP
    JAMA; 1965 Dec; 194(11):1203-5. PubMed ID: 5897741
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of 14C-dextroamphetamine sulfate absorption by carbonic anhydrase inhibition.
    Schnell RC; Miya TS; Chalmers RK
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):817-20. PubMed ID: 5791794
    [No Abstract]   [Full Text] [Related]  

  • 3. SUSTAINED-RELEASE ASPIRIN TABLET USING AN INSOLUBLE MATRIX.
    VORA MS; ZIMMER AJ; MANEY PV
    J Pharm Sci; 1964 May; 53():487-92. PubMed ID: 14193877
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo evaluation of absorption and excretion of pentylenetetrazol-10-14C from sustained-release and nonsustained-release tablets.
    Ebert WR; Morris RW; Rowles SG; Russell HT; Born GS; Christian JE
    J Pharm Sci; 1970 Oct; 59(10):1409-12. PubMed ID: 5471944
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered absorption of drugs from the rat small intestine by carbonic anhydrase inhibition.
    Schnell RC; Miya TS
    J Pharmacol Exp Ther; 1970 Aug; 174(2):177-84. PubMed ID: 4988984
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.
    James RS; Sharp WS; Bastain TM; Lee PP; Walter JM; Czarnolewski M; Castellanos FX
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1268-76. PubMed ID: 11699800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma d-amphetamine absorption and elimination in hyperactive children.
    Brown GL; Ebert MH; Hunt RD
    Psychopharmacol Bull; 1978 Jul; 14(3):33-5. PubMed ID: 674533
    [No Abstract]   [Full Text] [Related]  

  • 9. The dog as a quantitative model for evaluation of nondisintegrating sustained-release tablets.
    Cressman WA; Sumner D
    J Pharm Sci; 1971 Jan; 60(1):132-4. PubMed ID: 5548224
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactions to slow-release drugs.
    Stephen JM
    Br Med J; 1966 May; 1(5499):1360. PubMed ID: 5934384
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained-release dosage form of nitrofurantoin. Part 2. In vivo urinary excretion in man.
    Ertan G; Karasulu E; Abou-Nada M; Tosun M; Ozer A
    J Microencapsul; 1994; 11(2):137-40. PubMed ID: 8006760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous distribution of dextroamphetamine in rat brain after acute amphetamine administration.
    Valenzuela A; Pla A; Villanueva E
    J Toxicol Clin Exp; 1986; 6(6):369-76. PubMed ID: 3820126
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of sustained-release on the excretion of some metabolites of diethylopropion.
    Banci F; Cartoni GP; Cavalli A; Monai A
    Arzneimittelforschung; 1972 Oct; 22(10):1724-6. PubMed ID: 4677065
    [No Abstract]   [Full Text] [Related]  

  • 14. Objective and subjective tests in measuring response to CNS drugs in normal subjects.
    Bishop MP; Guthrie MB; Hornsby LD
    J Clin Pharmacol J New Drugs; 1969; 9(5):308-14. PubMed ID: 5259366
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.
    Rasmussen SN; Bondesen S; Hvidberg EF; Hansen SH; Binder V; Halskov S; Flachs H
    Gastroenterology; 1982 Nov; 83(5):1062-70. PubMed ID: 7117789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study in man of the absorption and excretion of amobarbital-14C from sustained-release and nonsustained-release dosage forms.
    Rosen E; Polk A; Free SM; Tannenbaum PJ; Crosley AP
    J Pharm Sci; 1967 Oct; 56(10):1285-7. PubMed ID: 6059449
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial.
    Nuijten M; Blanken P; van de Wetering B; Nuijen B; van den Brink W; Hendriks VM
    Lancet; 2016 May; 387(10034):2226-34. PubMed ID: 27015909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium absorption from ordinary and from sustained-release tablets.
    Otto U; Paalzow L; Surén G
    Acta Pharm Suec; 1972 Dec; 9(6):595-601. PubMed ID: 4656566
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood-brain barrier: I. Kinetics of the distribution of amphetamine H3-in brain structures of the rate after intravenous administration].
    Lindenbaum A; Marcher K; Wepierre J; Cohen Y
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):337-47. PubMed ID: 4614730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.